NNovo Nordisk Read More Novo Nordisk Pushes Deeper Into Obesity Science as Washington’s Pricing Hammer Looms2026-05-21 Novo Nordisk launches Phase 3 trial of Amycretin to prevent weight regain after diet, while a US drug…